BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Drug Development

  Xencor Announces 2018 Priorities and Expected Milestones

  The Company’s expected clinical development and research milestones are outlined.

  January 5, 2018

   · 

  7 min read
• Biotech Beach

  Sensifree Reports Statistically Significant Concordance of Arterial Pressure Signal Waveform Between its Continuous Non-invasive Blood Pressure Monitoring Technology and Invasive Arterial Line

  Preliminary results demonstrate accurate tracking of systolic and diastolic pressure values.

  January 5, 2018

   · 

  2 min read
• Deals

  Jiangsu Hengrui Medicine and Arcutis Announce a Development and Commercialization Partnership for Novel Immune-Mediated Dermatology Therapy Using SHR0302

  Jiangsu Hengrui Medicine and Arcutis today announced an exclusive option and license agreement for the development and commercialization of topical applications of Hengrui’s investigational drug, SHR0302.

  January 5, 2018

   · 

  3 min read
• Business

  Trieza Therapeutics Names Jeno Gyuris, Ph.D., as CSO

  Dr. Gyuris brings 25 years of scientific leadership experience in the biopharmaceutical industry and will lead all aspects of Trieza’s novel therapeutics discovery and development.

  January 5, 2018

   · 

  2 min read
• Pharm Country

  NovoPath Anatomic Pathology Software System Integrates With Philips IntelliSite Pathology Solution and Wholeslide Imaging System

  NovoPath announces the integration of the NovoPath Anatomic Pathology Software Platform with Philips IntelliSite Pathology Solution and Wholeslide Imaging System.

  January 5, 2018

   · 

  2 min read
• Business

  Lilly Confirms Date and Conference Call for Fourth-Quarter 2017 Financial Results Announcement

  Eli Lilly will announce its fourth-quarter and full-year 2017 financial results on Wednesday, January 31, 2018.

  January 5, 2018

   · 

  1 min read
• Business

  Retrophin and Censa Pharmaceuticals Enter Into Strategic Collaboration to Advance CNSA-001 for the Treatment of Phenylketonuria (PKU)

  Retrophin obtains exclusive option to purchase Censa post proof-of-concept study.

  January 5, 2018

   · 

  7 min read
• Business

  Distributed Bio Announces SuperHuman Platform License Agreement With Pfizer Inc.

  Distributed Bio announce an agreement with Pfizer Inc. to license the Distributed Bio SuperHuman Platform for the identification of novel antibodies for use as therapeutic agents.

  January 5, 2018

   · 

  3 min read
• Business

  Global Genomics Group and Datavant Announce Strategic Partnership to Improve Design and Interpretation of Clinical Trials

  Through this partnership, Datavant and G3 will work together to increase the odds of success and pace of drug development through data-driven approaches.

  January 5, 2018

   · 

  3 min read
• 

  Business

  Longtime CEO at Bay Area’s OncoMed Steps Down

  Board of Directors has initiated search to identify successor.

  January 5, 2018

   · 

  4 min read